Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Infusion Versus Intermittent Administration of Linezolid - Impact on Clinical Outcome and Adverse Reactions in Critically Ill Patients: a Pharmacokinetic and Pharmacodynamic Prospective Study

NCT05801484 is registered in ClinicalTrials.gov with Cluj Municipal Clinical Hospital as lead sponsor.

NCT NCT05801484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05801484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Infusion Versus Intermittent Administration of Linezolid - Impact on Clinical Outcome and Adverse Reactions in Critically Ill Patients: a Pharmacokinetic and Pharmacodynamic Prospective Study
Lead sponsor
Cluj Municipal Clinical Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 30, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, efficacy, intensive care unit icu, pharmacokinetics, side-effect of antibiotic